Kymera Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $508k | 20k | 25.46 |
| 2023-09-30 | $278k | 20k | 13.90 |
| 2023-06-30 | $459k | 20k | 22.99 |
| 2023-03-31 | $592k | 20k | 29.63 |
| 2022-12-31 | $498k | 20k | 24.96 |
| 2022-09-30 | $484k | 22k | 21.77 |
| 2022-06-30 | $379k | 19k | 19.69 |
| 2022-03-31 | $814k | 19k | 42.32 |
| 2021-12-31 | $778k | 12k | 63.49 |
| 2021-09-30 | $719k | 12k | 58.74 |
| 2021-06-30 | $542k | 11k | 48.50 |
| 2021-03-31 | $177k | 4.5k | 38.91 |
| 2020-12-31 | $282k | 4.5k | 62.00 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors